Objective: To describe the prevalence of MDRGN organisms within a LTACH.
Methods: All clinical microbiological records between January 1st 2005 and December 31st 2009 were reviewed. Cultures obtained for surveillance of colonization with MRSA or VRE were excluded, as were repeated cultures from a single individual within 30 days, and those without bacterial growth or “normal flora”. Information on antibiotic treatment, and disposition upon discharge from the LTACH was obtained for the calendar year January 1st 2009 – December 31st, 2009. MDRGN was defined as resistance to ≥3 antibiotics or antimicrobial classes.
Results: A total of 1,692 cultures were included in the analysis, with 1,138 demonstrating gram-negative bacteria; among these cultures 471(41.4%) met criteria for MDRGN. The prevalence of MDRGN was high among all sites of infections with 66.8% of respiratory, 53.1% of blood stream, 38.7% of urinary tract, and 36.3% of skin and wound infections respectively. The prevalence of MDRGN rose significantly during the study period (P<0.005). Rates of resistance to many individual antibiotics exceeded the 90th percentile reported for ICU’s participating in the National Nosocomial Infection Surveillance (NNIS) system. Transfer to another health care setting occurred for more than two thirds of the patients.
Conclusions: The prevalence of MDRGN is exceptionally high within the LTACH setting. High levels of individual and multi-drug antibiotic resistance create a daunting clinical challenge and few effective antibiotic choices. The frequent transition of LTACH residents to other health care settings raises concerns about the potential dissemination of MDRGN to other populations.